STAAR Surgical Company
NASDAQ:STAAMedical - Instruments & Supplies
-$0.40 today
- Market cap
- $1.27B
- Beta
- 1.23
- P/E (TTM)
- -68.3
- EPS (TTM)
- -$0.42
Volume 0.45M
Average 1.07M
STAA Net Receivables
Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.
STAAR Surgical CompanyNASDAQ: STAA
Net Receivables · Q1 FY2026 · quarter ended Apr 2026
Net receivables rises 100.7% from a year ago
Net receivables stood at $85.69M at the end of Q1 FY2026, up 100.7% from a year earlier and up 56.9% from the prior quarter. Over 3 fiscal years it compounded at -6.1% a year.
Context
- Net receivables amounted to 19.0% of total assets at the end of Q1 FY2026, up 9.7 pp from a year earlier.
- Net receivables increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether net receivables keeps rising in the next quarterly balance sheet after a +100.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Receivables history
USD · from the balance sheet
- Latest · FY2025
- 54.61M USD
- Year-over-year change
- -31.1%
- 4-year CAGR
- +4.1%
| Period | Period end | Net Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2026-01-02 | 54.61M | -31.1% |
| FY2024 | 2024-12-27 | 79.26M | -19.1% |
| FY2023 | 2023-12-29 | 97.98M | +48.5% |
| FY2022 | 2022-12-30 | 65.97M | +41.7% |
| FY2021 | 2021-12-31 | 46.56M | — |
Net Receivables vs competitors
How STAA compares with its peers on the latest reported figures
- STAA's Apr 2026 net receivables of $85.69M is the 4th highest of the 5 companies compared; the peer median is $974.45M.
- Its year-over-year change of +100.7% is the highest of 5, against a peer median of +3.1%.
- Net receivables amounts to 19.0% of total assets for STAA, versus a peer median of 7.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $2.07B | +6.6% | -0.8% | 6.6% | |
| Jun 2026 | $1.16B | +6.6% | +18.9% | 8.4% | |
| Jul 2026 | $788.9M | -0.4% | +14.1% | 6.2% | |
| Apr 2026 | $85.69M | +100.7% | -6.1% | 19.0% | |
| Mar 2026 | $22.44M | -27.5% | +28.8% | 7.4% | |
| Peer median (excluding STAA) | $974.45M | +3.1% | +16.5% | 7.0% | |
Competitors are the stored peer set for STAA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Jan 2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | 199.71M | 86.48M | 183.04M | 144.16M | 153.15M |
| Short-term Investments | 0 | 125.16M | 37.69M | 86.34M | 34.39M |
| Net Receivables | 46.56M | 65.97M | 97.98M | 79.26M | 54.61M |
| Inventory | 17.27M | 24.16M | 35.13M | 43.31M | 55.5M |
| Other Current Assets | 636K | 811K | 6.98M | 980K | 8.04M |
| Total Current Assets | 271.41M | 311.72M | 365.27M | 367.94M | 311.55M |
| Property, Plant & Equipment (Net) | 67.73M | 81.53M | 101.41M | 121.78M | 102.93M |
| Goodwill | 1.79M | 1.79M | 1.79M | 1.79M | 1.79M |
| Intangible Assets | 218K | 173K | 0 | 0 | 30.7M |
| Long-term Investments | 0 | 13.9M | 11.7M | 0 | 0 |
| Tax Assets | 3.81M | 8.74M | 5.19M | 788K | 13.31M |
| Other Non-current Assets | 822K | 957K | 3.34M | 17.23M | 1.35M |
| Total Non-current Assets | 74.37M | 107.1M | 123.42M | 141.58M | 150.07M |
| Total Assets | 345.78M | 418.82M | 488.69M | 509.52M | 461.62M |
| Account Payables | 8.7M | 11.58M | 13.56M | 16.7M | 11.57M |
| Short-term Debt | 0 | 0 | 0 | 0 | 0 |
| Tax Payables | 2.25M | 3.85M | 10.85M | 6.55M | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 22.42M | 21.74M | 21.43M | 24.28M | 34.2M |
| Total Current Liabilities | 48.8M | 51.72M | 65.04M | 70.31M | 68.5M |
| Long-term Debt | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 811K | 1.49M | 1.08M | 297K | 9.94M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 89K |
| Other Non-current Liabilities | 8.96M | 2.16M | 5.16M | 6.78M | 6.42M |
| Total Non-current Liabilities | 38.42M | 30.99M | 37.7M | 41.88M | 48.93M |
| Total Liabilities | 87.22M | 82.71M | 102.74M | 112.19M | 117.44M |
| Common Stock | 477K | 482K | 488K | 493K | 498K |
| Retained Earnings | (111.39M) | (68.72M) | (47.37M) | (67.58M) | (148.02M) |
| Accumulated OCI | (4.05M) | 156K | (4.11M) | (7.03M) | (6.51M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 258.56M | 336.11M | 385.95M | 397.34M | 344.18M |
| Total Debt | 32.06M | 31.04M | 35.83M | 38.74M | 38.35M |
| Net Debt | (167.65M) | (55.44M) | (147.2M) | (105.42M) | (114.8M) |
STAAR Surgical Company
NASDAQ:STAA
Intrinsic Alpha fair value
Locked
Current Price
$25.35
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.